Vaccinex Inc (VCNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1895 MOUNT HOPE AVE ROCHESTER, NY 14620

Vaccinex, Inc. is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The Company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that prevents immune infiltration into tumors and triggers chronic inflammation in the brain. The Company additionally intends to leverage its proprietary drug discovery platform, ActivMAb®, to create opportunities for future pipeline expansion and strategic collaborations, particularly by exploiting its unique capability to select high value antibodies against important multi-pass membrane receptors including GPCR and ion channels.

Data as of 2021-10-09 10:36:27 -0400
Market Cap62.218 Million Shares Outstanding30.801 Million Avg 30-day Volume70.519 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.82 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.20074 52-week High/Low9.56 / 1.64 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -10.7224
Data provided by IEX Cloud
View SEC Filings from VCNX instead.

View recent insider trading info

Funds Holding VCNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VCNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FRIEBERG JACOB B.

  • Director
176,753 2021-09-30 6

FRIEDBERG ALBERT

FCMI PARENT CO.

  • Director
  • 10% Owner
11,965,916 2021-05-24 1

MANIAN BALA S

  • Director
51,983 2021-05-11 1

YANNI BARBARA

  • Director
58,379 2021-05-11 1

GOATER JEFF

  • Director
60,522 2021-05-11 1

VAN STRYDONCK, GERALD E.

  • Director
75,358 2021-05-11 1

STECYK CHRYSTYNA BEDRIJ

  • Director
53,673 2021-05-11 1

EVANS ELIZABETH E. CHIEF OPERATING OFFICER

  • Officer
9,600 2021-05-11 1

ZAUDERER MAURICE PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
1,771,774 2021-04-02 1

ROYER SCOTT E. CHIEF FINANCIAL OFFICER

  • Officer
38,999 2021-04-02 1

SMITH ERNEST S. SVP, RESEARCH & CSO

  • Officer
71,839 2021-04-02 1

LEONARD JOHN E. SVP, DEVELOPMENT

  • Officer
44,484 2021-04-02 1

SCALA ROBERT CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-09-01 0

WATKINS RAYMOND E. SVP & CHIEF OPERATING OFFICER

  • Officer
7,850 2020-02-25 0

VACCINEX, INC.

  • Director
0 2019-09-30 0

BERLIN ALEJANDRO M.

  • Director
0 2019-05-15 0

FRIEDBERG ALBERT

VACCINEX (ROCHESTER), L.L.C.

  • Director
  • 10% Owner
5,850,990 2019-03-14 1

ZAUDERER MAURICE PRESIDENT AND CEO

VACCINEX (ROCHESTER), L.L.C.

  • Officer
  • Director
  • 10% Owner
1,418,816 2018-08-13 1

ANTIBODY INVESTMENTS LLC

SHUMACHER MICHAEL

  • 10% Owner
1,895,583 2018-08-13 0

CRANE ALAN L

  • Director
0 2018-08-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FRIEBERG JACOB B. - Director

2021-10-04 16:22:40 -0400 2021-09-30 A 6,233 a 6,233 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VACCINEX INC VCNX 2021-10-15 22:15:04 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 21:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 21:15:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 20:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 20:15:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 19:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 19:15:04 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 18:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 18:15:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 17:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 17:15:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 16:45:03 UTC -8.235 8.305 850000
VACCINEX INC VCNX 2021-10-15 16:15:03 UTC -8.235 8.305 650000
VACCINEX INC VCNX 2021-10-15 15:45:03 UTC -8.235 8.305 650000
VACCINEX INC VCNX 2021-10-15 15:15:03 UTC -8.235 8.305 600000
VACCINEX INC VCNX 2021-10-15 14:45:02 UTC -8.2571 8.3271 600000
VACCINEX INC VCNX 2021-10-15 14:15:03 UTC -8.2571 8.3271 600000
VACCINEX INC VCNX 2021-10-15 13:45:03 UTC -8.2571 8.3271 600000
VACCINEX INC VCNX 2021-10-15 13:15:03 UTC -8.2571 8.3271 600000
VACCINEX INC VCNX 2021-10-15 12:45:03 UTC -8.2571 8.3271 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VCNX -8800.0 shares, $-24640.0 2021-06-30 N-PORT

Elevate your investments